1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Percutaneous management of superior vena cava syndrome in patients with cardiovascular implantable electronic devices

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Most cited references34

          • Record: found
          • Abstract: not found
          • Article: not found

          2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA).

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Lead extraction in the contemporary setting: the LExICon study: an observational retrospective study of consecutive laser lead extractions.

              This study sought to examine the safety and efficacy of laser-assisted lead extraction and the indications, outcomes, and risk factors in a large series of consecutive patients. The need for lead extraction has been increasing in direct relationship to the increased numbers of cardiovascular implantable electronic devices. Consecutive patients undergoing transvenous laser-assisted lead extraction at 13 centers were included. Between January 2004 and December 2007, 1,449 consecutive patients underwent laser-assisted lead extraction of 2,405 leads (20 to 270 procedures/site). Median implantation duration was 82.1 months (0.4 to 356.8 months). Leads were completely removed 96.5% of the time, with a 97.7% clinical success rate whereby clinical goals associated with the indication for lead removal were achieved. Failure to achieve clinical success was associated with body mass index 10 years and when performed in low volume centers. Major adverse events in 20 patients were directly related to the procedure (1.4%) including 4 deaths (0.28%). Major adverse effects were associated with patients with a body mass index or =2.0. Indicators of all-cause in-hospital mortality were pocket infections, device-related endocarditis, diabetes, and creatinine > or =2.0. Lead extraction employing laser sheaths is highly successful with a low procedural complication rate. Total mortality is substantially increased with pocket infections or device-related endocarditis, particularly in the setting of diabetes, renal insufficiency, or body mass index <25 kg/m(2). Centers with smaller case volumes tended to have a lower rate of successful extraction. Copyright 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
                Bookmark

                Author and article information

                Contributors
                (View ORCID Profile)
                Journal
                Heart Rhythm
                Heart Rhythm
                Elsevier BV
                15475271
                March 2021
                March 2021
                : 18
                : 3
                : 392-398
                Article
                10.1016/j.hrthm.2020.11.012
                33212249
                a8c60d08-4acb-40ea-a268-591bc2bed462
                © 2021

                https://www.elsevier.com/tdm/userlicense/1.0/

                History

                Comments

                Comment on this article